
The study investigates Dysosmobacter welbionis abundance in individuals with obesity and diabetes, exploring its correlation with metabolic health, metformin treatment, and prebiotic intervention. D. welbionis levels were higher in metformin-treated participants, correlated with liver health and glucose metabolism, and associated with prebiotic response. Findings suggest a potential role for D. welbionis in metabolic health.
Like
Save
Share